| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 33,700 | $30 | $1.1M |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 161,000 | $1 | $644K |
| J3262 | Injection, tocilizumab, 1 mg | 78,360 | $10 | $391.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 35,340 | $10 | $388.7K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 29,610 | $10 | $236.9K |
| J0897 | Injection, denosumab, 1 mg | 11,100 | $20 | $199.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 930 | $100 | $92.1K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,420 | $30 | $88.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1,210 | $60 | $71.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 670 | $100 | $65.9K |